These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 15528217)

  • 21. The influence of interstitial collagenase-1 genotype polymorphism on colorectal cancer risk in Iranian population.
    Kouhkan F; Motovali-Bashi M; Hojati Z
    Cancer Invest; 2008 Oct; 26(8):836-42. PubMed ID: 18798060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Correlation of E-cadherin polymorphisms to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
    Zhang XF; Wang YM; Wang R; Wei LZ; Li Y; Guo W; Wang N; Zhang JH
    Ai Zheng; 2005 May; 24(5):513-9. PubMed ID: 15890089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No association between the polymorphisms in matrix metalloproteinase-1 and matrix metalloproteinase-3 promoter regions and colorectal cancer in Chinese.
    Xu E; Lai M; Lŭ B; Xing X; Huang Q
    Dis Colon Rectum; 2006 Sep; 49(9):1439-44. PubMed ID: 16937230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with mortality in haemodialysis patients.
    Cozzolino M; Biondi ML; Galassi A; Turri O; Brancaccio D; Gallieni M
    Nephrol Dial Transplant; 2009 Jul; 24(7):2207-12. PubMed ID: 19221176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer.
    Przybylowska K; Kluczna A; Zadrozny M; Krawczyk T; Kulig A; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J
    Breast Cancer Res Treat; 2006 Jan; 95(1):65-72. PubMed ID: 16267613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction between matrix metalloproteinase 3 and the epsilon4 allele of apolipoprotein E increases the risk of Alzheimer's disease in Finns.
    Saarela MS; Lehtimäki T; Rinne JO; Hervonen A; Jylhä M; Röyttä M; Ahonen JP; Mattila KM
    Neurosci Lett; 2004 Sep; 367(3):336-9. PubMed ID: 15337261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphism of matrix metalloproteinase genes (MMP1 and MMP3) in patients with varicose veins.
    Kurzawski M; Modrzejewski A; Pawlik A; Droździk M
    Clin Exp Dermatol; 2009 Jul; 34(5):613-7. PubMed ID: 19508478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A single-nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances bladder cancer susceptibility.
    Tasci AI; Tugcu V; Ozbek E; Ozbay B; Simsek A; Koksal V
    BJU Int; 2008 Feb; 101(4):503-7. PubMed ID: 17986285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The functional (-1171 5A-->6A) polymorphisms of matrix metalloproteinase 3 gene as a risk factor for oral submucous fibrosis among male areca users.
    Tu HF; Liu CJ; Chang CS; Lui MT; Kao SY; Chang CP; Liu TY
    J Oral Pathol Med; 2006 Feb; 35(2):99-103. PubMed ID: 16430740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of MMP-1 1G/2G promoter gene polymorphism on the development of prostate cancer in the Turkish population.
    Albayrak S; Cangüven O; Göktaş C; Aydemir H; Köksal V
    Urol Int; 2007; 79(4):312-5. PubMed ID: 18025848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer.
    Padala C; Tupurani MA; Puranam K; Gantala S; Shyamala N; Kondapalli MS; Gundapaneni KK; Mudigonda S; Galimudi RK; Kupsal K; Nanchari SR; Chavan U; Chinta SK; Mukta S; Satti V; Hanumanth SR
    PLoS One; 2017; 12(9):e0184448. PubMed ID: 28961241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matrix metalloproteinase 1 (MMP1) is associated with early-onset lung cancer.
    Sauter W; Rosenberger A; Beckmann L; Kropp S; Mittelstrass K; Timofeeva M; Wölke G; Steinwachs A; Scheiner D; Meese E; Sybrecht G; Kronenberg F; Dienemann H; ; Chang-Claude J; Illig T; Wichmann HE; Bickeböller H; Risch A
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1127-35. PubMed ID: 18483334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer.
    Shih CM; Lee YL; Chiou HL; Hsu WF; Chen WE; Chou MC; Lin LY
    Lung Cancer; 2005 Dec; 50(3):291-7. PubMed ID: 16122836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MMP gene polymorphisms as contributors for cleft lip/palate: association with MMP3 but not MMP1.
    Letra A; Silva RA; Menezes R; Astolfi CM; Shinohara A; de Souza AP; Granjeiro JM
    Arch Oral Biol; 2007 Oct; 52(10):954-60. PubMed ID: 17537400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: a meta-analysis.
    Hu C; Wang J; Xu Y; Li X; Chen H; Bunjhoo H; Xiong W; Xu Y; Zhao J
    Gene; 2013 Mar; 517(1):65-71. PubMed ID: 23313298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic variations in the matrix metalloproteinase-1 promoter and risk of susceptibility and/or severity of chronic periodontitis in the Czech population.
    Hollá LI; Jurajda M; Fassmann A; Dvorakova N; Znojil V; Vacha J
    J Clin Periodontol; 2004 Aug; 31(8):685-90. PubMed ID: 15257748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer.
    Woo M; Park K; Nam J; Kim JC
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1064-70. PubMed ID: 17608852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphisms in the promoter regions of the matrix metalloproteinases-7, -9 and the risk of endometriosis and adenomyosis in China.
    Shan K; Lian-Fu Z; Hui D; Wei G; Na W; Xia J; Yan L
    Mol Hum Reprod; 2006 Jan; 12(1):35-9. PubMed ID: 16455621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A study on the expression of CASP9 gene and its polymorphism distribution in non-small cell lung cancer].
    Lou Y; Fang CQ; Li JH
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):59-62. PubMed ID: 17285546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer.
    Rollin J; Régina S; Vourc'h P; Iochmann S; Bléchet C; Reverdiau P; Gruel Y
    Lung Cancer; 2007 May; 56(2):273-80. PubMed ID: 17208328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.